Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

108 results about "Lactobacillus crispatus" patented technology

Lactobacillus crispatus is a common, rod-shaped species of genus Lactobacillus and is a hydrogen peroxide (H₂O₂) producing beneficial micro biota species located in both the vagina, through vaginal discharge, and the vertebrate gastrointestinal. The strain CTV-05 is used as a probiotic that can be used by premenopausal and postmenopausal women that experience recurrent urinary tract infections. It is being evaluated specifically for the prevention and treatment of bacterial vaginosis, which is characterized by the absence of lactobacillus flora, also known as Lactobacillus acidophilus; which plays a large role in protecting the host from infection.

Lactobacillus crispatus and its application in gynecological diseases

ActiveCN104178437AStrong acid productionStrong production H <sub>2</sub> o <sub>2</sub> abilityAntibacterial agentsAntimycoticsBiotechnologyPharmaceutical Substances
The invention discloses a Lactobacillus crispatus 262-1 and its application in gynecological diseases. The Lactobacillus crispatus 262-1 is a new Lactobacillus crispatus strain, and has a preservation number of CGMCCNo.6469 in China General Microbiological Culture Collection Center. The Lactobacillus crispatus 262-1 has the advantages of strong acid and H2O2 production ability, strong adherence to vaginal epithelial cells, substantial resistance on bacterial vaginal diseases and various vaginal gynecological diseases, safety, non-toxicity, good stability and long term preservation. The invention also relates to a use of the Lactobacillus crispatus 262-1 in medicines for preventing and / or treating the gynecological diseases.
Owner:SUZHOU OSEL BIO PHARM

Active lactic acid bacteria capsules with treatment and prevention effect on vaginitis

The invention relates to active lactic acid bacteria capsules with a treatment and prevention effect on vaginitis. The lactic acid bacteria capsules capable of simultaneously adjusting dysbacteriosis of intestinal tracts and vagina and emphasizing treatment and prevention of the vaginitis are developed for achieving comprehensive effects. According to the technical scheme, excipient and lactic acid bacteria mixed bacteria powder are wrapped in the active lactic acid bacteria capsules with the treatment and prevention effect on vaginitis, and the lactic acid bacteria mixed bacteria powder comprises lactobacillus crispatus powder and other lactic acid bacteria subspecies powder with an effect of adjusting the intestinal flora. The active lactic acid bacteria capsules can be used for treating the vaginitis by adopting oral administration and intra-vaginal use; the oral lactobacillus can effectively improve the immunity of mucosa by stimulating the immune response of the intestinal mucosa, adjust the overall function state of a human body and well treat the vaginitis; and a large quantity of lactobacillus proliferated in the intestinal tract can inhibit growth of intestinal bacteria and reduce the risk of intestinal bacteria infection in vagina.
Owner:郑州金森生物科技工程有限公司

Probiotics-Chinese herbal medicine compound composition capable of loosening bowels to relieve constipation and application of probiotics-Chinese herbal medicine compound composition

The invention discloses a probiotics-Chinese herbal medicine compound composition capable of loosening bowels to relieve constipation and application of the probiotics-Chinese herbal medicine compoundcomposition and belongs to the technical field of health-care foods. The composition comprises 13-15 kinds of lactobacillus rhamnosus, lactobacillus plantarum, lactobacillus paracasei, bifidobacterium lactis, lactobacillus acidophilus, bifidobacterium longum, lactobacillus reuteri, lactobacillus helveticus, lactobacillus fermentum, lactobacillus johnsonii, lactobacillus casei, lactobacillus crispatus, bifidobacterium breve, bifidobacterium bifidum and bifidobacterium infantis, 10-13 kinds of isomalto-oligosaccharide, inulin, lactitol, stachyose, fructo-oligosaccharide, xylo-oligosaccharide, Mannan-oligosaccharide, galacto-oligosaccharide, oat beta-glucan, glucan, soluble soybean polysaccharide, resistant dextrin and chitosan-oligosaccharide and 2-4 kinds of malts, fructus crataegi, blackplums and fermented soybeans. According to the probiotics-Chinese herbal medicine compound composition and the application thereof, probiotics, prebiotics and traditional Chinese medicine powder are compounded and can jointly promote intestinal canal health.
Owner:青岛琛蓝生物营养技术有限公司

Lactobacillus for producing lactic acid and H2O2 and application of lactobacillus

ActiveCN111088178ALactic acid producing (strain B3 strongStrong B7Antibacterial agentsAntimycoticsBiotechnologyMicrobiology
The invention discloses lactobacillus for producing lactic acid and H2O2 and an application of the lactobacillus. The lactobacillus is lactobacillus gasseri or lactobacillus crispatus, wherein the preservation number of the lactobacillus gasseri is CGMCC No. 15815 or CGMCC No. 15816; the preservation number of the lactobacillus crispatus is CGMCC No. 15813 or CGMCC No. 15814. The lactobacillus gasseri and lactobacillus crispatus provided by the invention have extremely strong lactic acid and H2O2 production ability, have good ability to adhere to vaginal epithelial cells, and can effectively inhibit reproduction of pathogenic bacteria like Gardner bacteria and Candida albicans in in-vivo and in-vitro experiments.
Owner:SHANGHAI SINE PHARMA LAB

Lactobacillus crispatus strain and its uses

InactiveCN103911308AAchieve antagonismHigh lactic acid production capacityAntibacterial agentsAntimycoticsVaginal epithelial cellMicrobiology
The invention provides a strain. The strain is a Lactobacillus crispatus strain, and the preservation number of the strain is CGMCC No.6364. The invention also provides a use of the strain in the preparation of colpitis prevention and / or treatment drugs, a use of the strain in the preparation of vagina nursing articles, and a use of the strain in the preparation of external genitals health articles. By adopting the above technical scheme, the strain can effectively realize an antagonistic effect on a plurality of pathogenic bacteria. The strain has a high adherence ability to vaginal epithelial cell. The strain can well meet practical clinic application demands.
Owner:XINLIFEI BIOMEDICAL TECH TIANJIN

Lactobacillus crispatus and application thereof

The present invention discloses Lactobacillus crispatus 262-1 and an inoculum comprising such strain and application thereof. The Lactobacillus crispatus 262-1 is a new strain of Lactobacillus genus and is preserved in the China General Microbiological Culture Collection Center with a preservation number of CGMCC No. 6469. The Lactobacillus crispatus 262-1 particularly is the dominant bacteria in the vagina, has good acid and H2O2 production capability, good adhesion to the vaginal epithelial cells and significant resistance to bacterial vaginosis and various vaginal infections, and is characterized by safety, non-toxicity, good stability and long term preservation. The present invention also relates to the use of the Lactobacillus crispatus 262-1 in the preparation of pharmaceuticals for preventing and / or treating gynecological diseases and its application in feminine care products such as medical instruments, disinfect products or cosmetics.
Owner:SUZHOU OSEL BIO PHARM

Lactobacillus crispatus and application thereof

The invention discloses lactobacillus crispatus and application thereof. The perseveration number of the lactobacillus crispatus is as follows: CGMCC No.9388. The lactobacillus crispatus IMC-12 disclosed by the invention has relatively strong capacity of producing H2O2 and can be used for effectively inhibiting the growth of external pathogenic bacteria and other conditioned pathogenic bacteria and meanwhile, the lactobacillus cripatus has relatively strong adhesive attraction for vagina epithelial cells, so that the field planting of the vagina epithelial cell is guaranteed, and thus, the lactobacillus crispatus IMC-12 has certain application prospect in preventing and treating urogenital tract infection.
Owner:北京益生苑生物科技有限公司

Complex microbial agent and application thereof in aerobic repair of landfill

The invention relates to the field of garbage disposal, in particular to a complex microbial agent and an application thereof in aerobic repair of landfill. The complex microbial agent contains an type-I complex microbial agent and / or a type-II complex microbial agent, wherein the type-I complex microbial agent is prepared from streptomyces badius, lactobacillus crispatus, bacillus megatherium, bacillus subtilis, bacillus licheniformis and active dry yeast; the type-II complex microbial agent is prepared from phanerochaete chrysosporium, bacillus cereus, paracoccus denitrificans, candida utilis and rhodococcus erythropolis. The complex microbial agent is an efficient microbial agent prepared by massive screening and compounding according to specificity of nature change of garbage components, environmental factors and pollutants in the aerobic repair process of the landfill. The two types of microbial agents are added selectively in the aerobic repair process of the landfill by stages,and by means of function specificity of the microbial agents, the aerobic repair operating effect of the landfill is enhanced, the treatment cycle is shortened, and the operating cost is reduced.
Owner:BEIJING GEOENVIRON ENG & TECH

Swine lactobacillus crispatus and application thereof

The invention provides acid-resistant and bile-salt-resistant lactobacillus crispatus. The strain has the preservation name of lactobacillus crispatus ZLC020. The preservation number is CGMCC No.11531. The strain disclosed by the invention has excellent anti-bacterium performance; the obvious bacteriostatic effect is achieved on swine escherichia coli. The strain, the relevant strain and relevantfeed can improve the production performance of growth pig; the intestinal flora composition is improved; the body amino acid metabolism is promoted; good development and application prospects are realized.
Owner:BEIJING ACADEMY OF AGRICULTURE & FORESTRY SCIENCES

III-type bacteriocin from L. crispatus, and preparation method and applications thereof

The invention discloses III-type bacteriocin Helveticin-M molecular from L. crispatus. The Helveticin-M molecular possesses antibacterial effect, and is a polypeptide selected from polypeptide (a), polypeptide (b), or polypeptide (c). The polypeptide (a) is obtained via coding of a DNA molecular with a base sequence represented by SEQ ID NO:1; the polypeptide (b) is obtained via coding of a DNA molecular with a base sequence represented by SEQ ID NO:2; and the polypeptide (a) is a derivative of polypeptide (b), is obtained via substitution, deletion, or addition of one or a plurality of amino acids, and possesses antibacterial activity. The invention also discloses a DNA molecular used for coding Helveticin-M molecular. The invention also discloses a preparation method of III-type bacteriocin Helveticin-M molecular, and applications of III-type bacteriocin Helveticin-M molecular, the DNA molecular, recombinant vectors, or host cells in food preservation bacteria inhibition and decomposition inhibition. The III-type bacteriocin Helveticin-M molecular possesses antibacterial activity, and can be used in food fresh keeping; heterologous expression can be realized; and the preparation method possesses guidance meaning in research and study on III-type bacteriocin.
Owner:JIANGSU ACADEMY OF AGRICULTURAL SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products